PHARMA MAR, S.A. «...1112131415...» Page 14 out of 22 29/07/2021 16:24 PHARMA MAR, S.A. Other relevant information - On business and financial situation The Company sends press release regarding first half 2021 results and announces a conference call with analysts and investors. Register number: 11026 29/07/2021 16:16 PHARMA MAR, S.A. Half-yearly financial reports and audit reports/limited audit review La sociedad remite información financiera del primer semestre de 2021 Register number: 11022 28/07/2021 11:20 PHARMA MAR, S.A. On business and financial situation COMP, from the EMA, has given its positive opinion for the approval of Orphan Drug status to Zepzelca® (lurbinectedin) for the treatment of Mesothelioma Register number: 10916 13/07/2021 11:21 PHARMA MAR, S.A. Liquidity and counterparty agreements The Company enters into a liquidity agreement with JB Capital Markets, Sociedad de Valores, S.A.U. Register number: 10583 25/06/2021 14:30 PHARMA MAR, S.A. Liquidity and counterparty agreements The Company announces the termination of the liquidity agreement entered into on June, 4, 2018 with JB Capital Markets, Sociedad de Valores, S.A.U. Register number: 10195 20/05/2021 14:50 PHARMA MAR, S.A. General Shareholders’ Meeting Regulations La sociedad remite el Reglamento de la junta general de accionistas Register number: 9527 05/05/2021 08:23 PHARMA MAR, S.A. On business and financial situation The Company files first quarter 2021 financial information. Register number: 9162 29/04/2021 13:27 PHARMA MAR, S.A. On business and financial situation The Company announces that it has obtained the authorization from the Spanish Agency for Medicines and Health Products (AEMPS) to initiate the Phase III NEPTUNO. Register number: 9011 23/04/2021 08:24 PHARMA MAR, S.A. On business and financial situation The Company announces its licensing partner, Specialised Therapeutics Asia, Pte. Ltd. (STA) received marketing approval for Yondelis® (trabectedin) by the Australian Therapeutic Goods Administration (TGA). Register number: 8811 15/04/2021 14:35 PHARMA MAR, S.A. On corporate governance The Company reports changes in the composition of its Board of Directors and of its Appointments and Compensation and Sustainability Committee. Register number: 8665 Page 14 out of 22 «...1112131415...»
